SHUKRA PHARMACEUTICALS
Back to All Ratios
|
SHUKRA PHARMACEUTICALS Last 5 Year Cash Earnings per Share (CEPS) History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 0.29 | 0.47 | 0.40 | 0.08 | 0.06 |
What is the latest Cash Earnings per Share (CEPS) ratio of SHUKRA PHARMACEUTICALS ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2025 | 0.29 |
| Mar2024 | 0.47 |
| Mar2023 | 0.40 |
| Mar2022 | 0.08 |
| Mar2021 | 0.06 |
How is Cash Earnings per Share (CEPS) of SHUKRA PHARMACEUTICALS Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2025 | 0.29 | -38.30 | |
| Mar2024 | 0.47 | 17.50 | |
| Mar2023 | 0.4 | 400.00 | |
| Mar2022 | 0.08 | 33.33 | |
| Mar2021 | 0.06 | - | |
Other Financial Ratios of SHUKRA PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹1,333.7 Cr | -4.6% | -15.9% | 127.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,591.0 Cr | 3.2% | 12.4% | 11.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹183,512.0 Cr | 1.8% | 11% | 10.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,850.0 Cr | 3.8% | 6.7% | 35.5% | Stock Analytics | |
| CIPLA | ₹113,884.0 Cr | 6.2% | 13.9% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,339.0 Cr | 5.4% | 8% | 9.1% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | -4.6% |
-15.9% |
127.8% |
| SENSEX | 0.9% |
-3.6% |
-7.3% |
You may also like the below Video Courses